Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles

Biochem J. 2004 Feb 15;378(Pt 1):239-46. doi: 10.1042/BJ20031660.

Abstract

Circulating levels of glucocorticoids are increased in many traumatic and muscle-wasting conditions that include insulin-dependent diabetes, acidosis, infection, and starvation. On the basis of indirect findings, it appeared that these catabolic hormones are required to stimulate Ub (ubiquitin)-proteasome-dependent proteolysis in skeletal muscles in such conditions. The present studies were performed to provide conclusive evidence for an activation of Ub-proteasome-dependent proteolysis after glucocorticoid treatment. In atrophying fast-twitch muscles from rats treated with dexamethasone for 6 days, compared with pair-fed controls, we found (i) increased MG132-inhibitable proteasome-dependent proteolysis, (ii) an enhanced rate of substrate ubiquitination, (iii) increased chymotrypsin-like proteasomal activity of the proteasome, and (iv) a co-ordinate increase in the mRNA expression of several ATPase (S4, S6, S7 and S8) and non-ATPase (S1, S5a and S14) subunits of the 19 S regulatory complex, which regulates the peptidase and the proteolytic activities of the 26 S proteasome. These studies provide conclusive evidence that glucocorticoids activate Ub-proteasome-dependent proteolysis and the first in vivo evidence for a hormonal regulation of the expression of subunits of the 19 S complex. The results suggest that adaptations in gene expression of regulatory subunits of the 19 S complex by glucocorticoids are crucial in the regulation of the 26 S muscle proteasome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphatases / biosynthesis
  • Adenosine Triphosphatases / genetics
  • Animals
  • Chymotrypsin / metabolism
  • Culture Techniques
  • Cysteine Endopeptidases / biosynthesis
  • Cysteine Endopeptidases / genetics
  • Cysteine Endopeptidases / metabolism
  • Cysteine Proteinase Inhibitors / pharmacology
  • Dexamethasone / pharmacology*
  • Endopeptidases / biosynthesis
  • Endopeptidases / genetics
  • Gene Expression Regulation
  • Glucocorticoids / pharmacology*
  • Leupeptins / pharmacology
  • Male
  • Multienzyme Complexes / biosynthesis
  • Multienzyme Complexes / genetics
  • Multienzyme Complexes / metabolism
  • Muscle Fibers, Fast-Twitch / drug effects
  • Muscle Fibers, Fast-Twitch / metabolism*
  • Muscle Proteins / metabolism
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism*
  • Muscular Atrophy / etiology
  • Peptide Hydrolases / biosynthesis*
  • Peptide Hydrolases / genetics
  • Proteasome Endopeptidase Complex
  • Protein Subunits / biosynthesis
  • Protein Subunits / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Ubiquitins / metabolism

Substances

  • Cysteine Proteinase Inhibitors
  • Glucocorticoids
  • Leupeptins
  • Multienzyme Complexes
  • Muscle Proteins
  • Protein Subunits
  • RNA, Messenger
  • Ubiquitins
  • Dexamethasone
  • Endopeptidases
  • Peptide Hydrolases
  • Chymotrypsin
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex
  • ATP dependent 26S protease
  • 26S proteasome non-ATPase regulatory subunit 13
  • Adenosine Triphosphatases
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde